Effect of calcium plus Vitamin-D combined with calcitriol in the treatment of patients with Type-2 diabetes and osteoporosis: A retrospective observational analysis
- PMID: 38356827
- PMCID: PMC10862466
- DOI: 10.12669/pjms.40.3.8795
Effect of calcium plus Vitamin-D combined with calcitriol in the treatment of patients with Type-2 diabetes and osteoporosis: A retrospective observational analysis
Abstract
Objective: To explore the clinical effect of calcium plus Vitamin-D combined with calcitriol in the treatment of patients with type-2 diabetes mellitus (T2DM) patients and osteoporosis.
Methods: In this retrospective observational study clinical records of 90 patients with T2DM combined with osteoporosis, treated in The Quzhou Affiliated Hospital of Wenzhou Medical University from October 2019 to April 2022 were incuded. All patients received basic hypoglycemic treatment. Of 90 patients, 43 received calcium plus Vitamin-D adjuvant therapy (Control-group), and 47 patients received calcium plus Vitamin-D combined with calcitriol adjuvant therapy (Observation-group). Clinical efficacy, adverse reactions, bone metabolism levels, and changes in bone density levels were compared between the two groups.
Results: The clinical efficacy of the treatment was significantly higher in the Observation-group (93.6%) compared to the Control-group (83.7%; p<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (p>0.05). After treatment, bone metabolism and bone density indicators in both groups improved, and were significantly better in the Observation-group compared to the Control-group (p<0.05).
Conclusions: Combination of calcium plus Vitamin-D and calcitriol adjuvant therapy in patients with T2DM and osteoporosis is safe and associated with better treatment efficacy, improved bone metabolism and bone density parameters than calcium plus Vitamin-D treatment alone.
Keywords: Calcitriol; Calcium plus Vitamin-D; Osteoporosis; Type-2 diabetes.
Copyright: © Pakistan Journal of Medical Sciences.
Similar articles
-
Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.J Bone Miner Res. 2003 May;18(5):919-24. doi: 10.1359/jbmr.2003.18.5.919. J Bone Miner Res. 2003. PMID: 12733733 Clinical Trial.
-
Efficacy of Danshen injection combined with Calcitriol and Calcium/Vitamin-D for the treatment of osteoporotic fractures: A retrospective case-control study.Pak J Med Sci. 2024 Jan-Feb;40(3Part-II):291-296. doi: 10.12669/pjms.40.3.8513. Pak J Med Sci. 2024. PMID: 38356835 Free PMC article.
-
Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome: an open-label, randomized controlled study.Clin Nephrol. 2015 Nov;84(5):262-9. doi: 10.5414/CN108473. Clin Nephrol. 2015. PMID: 26396095 Clinical Trial.
-
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.CMAJ. 1996 Oct 1;155(7):955-61. CMAJ. 1996. PMID: 8837546 Free PMC article. Review.
-
Rationale for active vitamin D and analogs in the treatment of osteoporosis.J Cell Biochem. 2003 Feb 1;88(2):381-6. doi: 10.1002/jcb.10328. J Cell Biochem. 2003. PMID: 12520540 Review.
Cited by
-
Can the geriatric nutritional risk index predict the risk of osteoporosis in the elderly? A systematic review and meta-analysis.Pak J Med Sci. 2025 Apr;41(4):1219-1225. doi: 10.12669/pjms.41.4.11539. Pak J Med Sci. 2025. PMID: 40290237 Free PMC article. Review.
References
-
- Han L, Ma J, Wang S, Li Z. Evaluation of bone mineral density in patients with gestational diabetes mellitus by ultrasonic bone mineral density measurement combined with Vitamin-D deficiency and analysis of influencing factors. Pak J Med Sci. 2022;38(4Part-II):933–938. doi:10.12669/pjms.38.4.5090. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous